- Home
- CATX vs EVM Comparison
CATX vs EVM Comparison
Compare CATX & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CATX
- EVM
- Stock Information
- Founded
- CATX 1983
- EVM 2002
- Country
- CATX United States
- EVM United States
- Employees
- CATX N/A
- EVM N/A
- Industry
- CATX Medical/Dental Instruments
- EVM Finance/Investors Services
- Sector
- CATX Health Care
- EVM Finance
- Exchange
- CATX Nasdaq
- EVM Nasdaq
- Market Cap
- CATX 239.0M
- EVM 235.5M
- IPO Year
- CATX N/A
- EVM N/A
- Fundamental
- Price
- CATX $3.87
- EVM $9.55
- Analyst Decision
- CATX Strong Buy
- EVM
- Analyst Count
- CATX 10
- EVM 0
- Target Price
- CATX $12.90
- EVM N/A
- AVG Volume (30 Days)
- CATX 835.6K
- EVM 55.8K
- Earning Date
- CATX 11-11-2025
- EVM 01-01-0001
- Dividend Yield
- CATX N/A
- EVM 4.01%
- EPS Growth
- CATX N/A
- EVM N/A
- EPS
- CATX N/A
- EVM 0.20
- Revenue
- CATX $1,235,000.00
- EVM N/A
- Revenue This Year
- CATX N/A
- EVM N/A
- Revenue Next Year
- CATX N/A
- EVM N/A
- P/E Ratio
- CATX N/A
- EVM $47.61
- Revenue Growth
- CATX N/A
- EVM N/A
- 52 Week Low
- CATX $1.60
- EVM $7.67
- 52 Week High
- CATX $13.44
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- CATX 53.74
- EVM 67.29
- Support Level
- CATX $3.37
- EVM $9.53
- Resistance Level
- CATX $3.78
- EVM $9.74
- Average True Range (ATR)
- CATX 0.20
- EVM 0.07
- MACD
- CATX 0.04
- EVM -0.01
- Stochastic Oscillator
- CATX 66.14
- EVM 37.59
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.